Patients with Primary Sjögren's Syndrome Have Alterations in Absolute Quantities of Specific Peripheral Leucocyte Populations

Scandinavian Journal of Immunology

Volumn 86, Issue 6, 2017, Pages 491-502

  Davies, R ^a   Hammenfors, D ^a,b   Bergum, B ^a   Jakobsen, K ^a   Solheim, M ^a   Vogelsang, P ^a   Brun, J G ^a,b   Bryceson, Y ^a,c   Jonsson, R ^a,b   Appel, S ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD38 ANTIGEN; ANTINUCLEAR ANTIBODY; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCYTE; NATURAL KILLER CELL; NATURAL KILLER T CELL; PRIORITY JOURNAL; SJOEGREN SYNDROME; AGED; BLOOD; CIRCULATION; CLUSTER ANALYSIS; DISEASE EXACERBATION; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; PATHOLOGY;

AGED; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD; BLOOD CIRCULATION; CLUSTER ANALYSIS; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; SJOGREN'S SYNDROME;

EID: 85034958285     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12622     Document Type: Article

References (33)

1. Jonsson R, Vogelsang P, Volchenkov R et al. The complexity of Sjogren's syndrome: novel aspects on pathogenesis. Immunol Lett 2011;141:1–9.
2. Johnsen SJ, Brun JG, Goransson LG et al. Risk of non-Hodgkin's lymphoma in primary Sjogren's syndrome: a population-based study. Arthritis Care Res 2013;65:816–21.
3. Baer AN, Maynard JW, Shaikh F et al. Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset. J Rheumatol 2010;37:1143–9.
4. Antero DC, Parra AG, Miyazaki FH et al. Secondary Sjogren's syndrome and disease activity of rheumatoid arthritis. Rev Assoc Med Bras 2011;57:319–22.
5. Goransson LG, Haldorsen K, Brun JG et al. The point prevalence of clinically relevant primary Sjogren's syndrome in two Norwegian counties. Scand J Rheumatol 2011;40:221–4.
6. Mavragani CP, Nezos A, Moutsopoulos HM. New advances in the classification, pathogenesis and treatment of Sjogren's syndrome. Curr Opin Rheumatol 2013;25:623–9.
7. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–8.
8. Jonsson R, Theander E, Sjostrom B et al. Autoantibodies present before symptom onset in primary Sjogren syndrome. JAMA 2013;310:1854–5.
9. Theander E, Jonsson R, Sjostrom B et al. Prediction of Sjogren's syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling. Arthritis Rheumatol 2015;67:2427–36.
10. Shiboski CH, Shiboski SC, Seror R et al. 2016 American College of Rheumatology/European League against rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 2017;76:9–16.
11. Shiboski CH, Shiboski SC, Seror R et al. 2016 American College of Rheumatology/European League against rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017;69:35–45.
12. Theander E, Vasaitis L, Baecklund E et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome. Ann Rheum Dis 2011;70:1363–8.
13. Erkeller-Yusel F, Hulstaart F, Hannet I et al. Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus 1993;2:227–31.
14. Zhang L, Li JM, Liu XG et al. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 2011;31:606–14.
15. Ye Y, Liu J, Lai Q et al. Decreases in activated CD8 T cells in patients with severe hepatitis B are related to outcomes. Dig Dis Sci 2015;60:136–45.
16. Izumi Y, Ida H, Huang M et al. Characterization of peripheral natural killer cells in primary Sjogren's syndrome: impaired NK cell activity and low NK cell number. J Lab Clin Med 2006;147:242–9.
17. + T cells with lymphocyte activation and activity of disease in patients with primary Sjogren's syndrome. Arthritis Rheum 1999;42:1673–81.
18. Alunno A, Carubbi F, Bistoni O et al. CD4(−)CD8(−) T-cells in primary Sjogren's syndrome: association with the extent of glandular involvement. J Autoimmun 2014;51:38–43.
19. Goto Y, Itoh M, Ogawa N et al. Increased production of B cell growth factor (BCGF) in Sjogren's syndrome. J Autoimmun 1996;9:545–50.
20. Mandl T, Bredberg A, Jacobsson LT et al. CD4 + T-lymphocytopenia–a frequent finding in anti-SSA antibody seropositive patients with primary Sjogren's syndrome. J Rheumatol 2004;31:726–8.
21. Le S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw 2008;25:1–18.
22. Sudzius G, Mieliauskaite D, Siaurys A et al. Distribution of peripheral lymphocyte populations in primary Sjogren's syndrome patients. J Immunol Res 2015;2015:854706.
23. Mingueneau M, Boudaoud S, Haskett S et al. Cytometry by time-of-flight immunophenotyping identifies a blood Sjogren's signature correlating with disease activity and glandular inflammation. J Allergy Clin Immunol 2016;137:1809–21 e12.
24. Rusakiewicz S, Nocturne G, Lazure T et al. NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Sci Transl Med 2013;5:195ra96.
25. Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J Autoimmun 2010;34:400–7.
26. Moutsopoulos HM, Hooks JJ, Chan CC et al. HLA-DR expression by labial minor salivary gland tissues in Sjogren's syndrome. Ann Rheum Dis 1986;45:677–83.
27. Nakamura S, IkebeHiroki A, Shinohara M et al. An association between salivary gland disease and serological abnormalities in Sjogren's syndrome. J Oral Pathol Med 1997;26:426–30.
28. Simon SI, Kim MH. A day (or 5) in a neutrophil's life. Blood 2010;116:511–2.
29. Kaplan MJ. Role of neutrophils in systemic autoimmune diseases. Arthritis Res Ther 2013;15:219.
30. Gudbjornsson B, Feltelius N, Hallgren R et al. Neutrophil function in patients with primary Sjogren's syndrome: relation to infection propensity. Ann Rheum Dis 1991;50:685–90.
31. Shoenfeld Y, Gurewich Y, Gallant LA et al. Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis. Am J Med 1981;71:773–8.
32. Fauci AS, Dale DC. Alternate-day prednisone therapy and human lymphocyte subpopulations. J Clin Invest 1975;55:22–32.
33. Meng XW, Feller JM, Ziegler JB et al. Induction of apoptosis in peripheral blood lymphocytes following treatment in vitro with hydroxychloroquine. Arthritis Rheum 1997;40:927–35.